R&D
Why the best CROs challenge the trial plan and keep challeng...
Too often, oncology trials fail for reasons that could have been anticipated and addressed.
Digital
AI is exposing a new digital maturity divide in pharma busin...
As AI adoption increases, it is exposing just how prepared organisations really are to operate in a digitally connected environment.
Digital
Radiology has been optimising the wrong metric
Report turnaround time has become a key metric for diagnostic centres, shaping much of the automation built around their work.
Sales & Marketing
Sponsored
Solution Spotlight: BrandPRO Biopharma
Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test
Oncology
On the benefits of earlier oncological intervention, with Jo...
As ESMO 2026 came to a close, pharmaphorum web editor Nicole Raleigh spoke with Johnson & Johnson Innovative Medicine’s Carolyn Sousa and Henar Hevia
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
